US Senate IVF bill fails after Republicans block it, despite Trump support
Updates throughout with results of the vote
By Moira Warburton
WASHINGTON, Sept 17 (Reuters) -A U.S. Senate bill aimed at enshrining federal protections and expanding insurance coverage for fertility treatments failed on Tuesday, as Republicans voted against it days after Donald Trump surprised supporters by voicing support for such a policy.
The bill failed 51-44, falling short of the required 60-vote threshold after most Republicans voted against it for the second time. Democrats control the chamber by a slim 51-49 margin.
The bill's sponsor, Democratic Senator Tammy Duckworth, first attempted to get a vote on the same bill in late February, after the Alabama Supreme Court ruled the embryos used in in vitro fertilization, or IVF, should be considered children, jeopardizing access to the treatment used by millions of Americans every year.
"The freedom to get reproductive care is at risk for millions of other women whose most desperate hope in the world is to have a little one of their own," Duckworth, who had her two daughters via fertility treatments, said in a Senate floor speech after Tuesday's vote. "Republicans only seem to care about protecting life when it supposedly consists of some cells in a medical lab freezer."
Republican presidential candidate Trump said in August he would require the government or insurance companies to pay for IVF if he is elected, surprising some hardline Republicans for whom the treatment is controversial.
"We want to produce babies in this country, right?" Trump said during a town hall-style campaign event in La Crosse, Wisconsin.
Trump's campaign did not immediately respond to a request for comment on Tuesday.
Reporting by Moira Warburton in Washington; editing by Jonathan Oatis
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
